stage ia uterine corpus cancer

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Adenocarcinoma, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer Trial in Bronx (drug, radiation,

Terminated
  • Endometrial Adenocarcinoma
  • +8 more
  • Bronx, New York
    Albert Einstein College of Medicine
Apr 21, 2021

Estrogen Receptor Positive, Obesity, Progesterone Receptor Positive Trial in Los Angeles (dietary supplement, behavioral, other)

Withdrawn
  • Estrogen Receptor Positive
  • +5 more
  • Dietary Intervention
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 15, 2020

Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer, Stage II Uterine Corpus Cancer Trial in Bronx (Exercise

Completed
  • Stage IA Uterine Corpus Cancer
  • +7 more
  • Exercise Intervention
  • Bronx, New York
    Albert Einstein College of Medicine
Sep 13, 2019

Complex Endometrial Hyperplasia With Atypia, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer Trial in Cleveland

Completed
  • Complex Endometrial Hyperplasia With Atypia
  • +3 more
  • Weight Loss Specialist
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Nov 15, 2018

Stage I Breast Cancer, Stage I Cervical Cancer, Stage I Ovarian Cancer Trial in Philadelphia, Reading (Informational

Completed
  • Stage I Breast Cancer
  • +38 more
  • Informational Intervention
  • Philadelphia, Pennsylvania
  • +1 more
Feb 20, 2018

Lymphedema, Stage IA Cervical Cancer, Stage IA Uterine Corpus Cancer Trial in United States (Quality-of-Life Assessment,

Unknown status
  • Lymphedema
  • +13 more
  • Quality-of-Life Assessment
  • +5 more
  • Birmingham, Alabama
  • +212 more
May 3, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016